Ma Q F, Kenyon G L, Markham G D
Department of Pharmaceutical Chemistry, University of California, San Francisco 94143.
Biochemistry. 1990 Feb 13;29(6):1412-6. doi: 10.1021/bi00458a011.
The entire family of ATP analogues that are either mono- or disubstituted with imido and methylene bridges in the polyphosphate chain of ATP have been investigated as substrates and inhibitors of S-adenosylmethionine synthetase (ATP:L-methionine S-adenosyltransferase). The disubstituted analogues adenosine 5'-(alpha,beta:beta,gamma-diimidotriphosphate) (AMPNPNP) and adenosine 5'-(alpha,beta:alpha,beta'-diimidotriphosphate) [AMP(NP)2] have been synthesized for the first time, and a new route to adenosine 5'-(alpha,beta:beta,gamma-dimethylenetriphosphate) (AMPCPCP) has been developed. S-Adenosylmethionine synthetase catalyzes a two-step reaction: the intact polyphosphate chain is displaced from ATP, yielding AdoMet and tripolyphosphate, followed normally, but not obligatorily, by the hydrolysis of the tripolyphosphate to pyrophosphate and orthophosphate. Uniformly, the imido mono- or disubstituted derivatives are both better substrates and better inhibitors than their methylene counterparts. AMPNPNP reacts rapidly to give a single equivalent of product per active site, but subsequent turnovers are at least 1000-fold slower, enabling it to be used to quantify enzyme active site concentrations. In contrast, AMPCPCP is not detectably a substrate (less than 10(-5)% of ATP). AMP(NP)2, a branched isomer of linear AMPNPNP, was not a substrate but was a linear competitive inhibitor, greater than 100 fold more potent than ADP, indicating a reasonable degree of bulk tolerance at the alpha-phosphoryl group binding site.(ABSTRACT TRUNCATED AT 250 WORDS)
已对ATP类似物的整个家族进行了研究,这些类似物在ATP的多磷酸链中被亚氨基和亚甲基桥单取代或双取代,作为S-腺苷甲硫氨酸合成酶(ATP:L-甲硫氨酸S-腺苷转移酶)的底物和抑制剂。首次合成了双取代类似物腺苷5'-(α,β:β,γ-二亚氨基三磷酸)(AMPNPNP)和腺苷5'-(α,β:α,β'-二亚氨基三磷酸)[AMP(NP)2],并开发了一条合成腺苷5'-(α,β:β,γ-二亚甲基三磷酸)(AMPCPCP)的新路线。S-腺苷甲硫氨酸合成酶催化两步反应:完整的多磷酸链从ATP上被取代,生成S-腺苷甲硫氨酸和三聚磷酸,随后通常但非必然地,三聚磷酸水解为焦磷酸和正磷酸。一致地,亚氨基单取代或双取代衍生物既是比其亚甲基对应物更好的底物,也是更好的抑制剂。AMPNPNP反应迅速,每个活性位点产生一个当量的产物,但随后的周转至少慢1000倍,使其能够用于定量酶活性位点浓度。相比之下;AMPCPCP未被检测到是底物(小于ATP的10^-5%)。AMP(NP)2是线性AMPNPNP的支链异构体,不是底物而是线性竞争性抑制剂,其效力比ADP大100倍以上,表明在α-磷酰基结合位点有一定程度的体积耐受性。(摘要截短于250字)